Immunovant, Inc. - Common Stock (NQ:IMVT)
All News about Immunovant, Inc. - Common Stock

Immunovant Could Potentially Be An M&A Target, Writes Analyst
February 15, 2023
Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For February 15, 2023
February 15, 2023
Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For February 13, 2023
February 13, 2023
Via Benzinga

Analyst Expectations for Immunovant's Future
February 07, 2023
Via Benzinga

















Via Benzinga

Why Senti Biosciences Shares Jumped Over 50%; Here Are 79 Biggest Movers From Yesterday
September 30, 2022
Via Benzinga

Immunovant's New Candidate Provides Some Strategic Flexibility & Clarity, Analysts Say
September 29, 2022
Via Benzinga





Benzinga's Top Ratings Upgrades, Downgrades For September 26, 2022
September 26, 2022
Via Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.